A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/18341782/ below:

Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs

Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs

Affiliations

Affiliation

Item in Clipboard

Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs

Florence K L Tangka et al. Prev Chronic Dis. 2008 Apr.

Affiliation

Item in Clipboard

Abstract

Introduction: In 2005, the Centers for Disease Control and Prevention (CDC) started a 3-year colorectal cancer screening demonstration project and funded five programs to explore the feasibility of a colorectal cancer program for the underserved U.S. population. CDC is evaluating the five programs to estimate implementation cost, identify best practices, and determine the most cost-effective approach. The objectives are to calculate start-up costs and estimate funding requirements for widespread implementation of colorectal cancer screening programs.

Methods: An instrument was developed to collect data on resource use and related costs. Costs were estimated for start-up activities, including program management, database development, creation of partnerships, public education and outreach, quality assurance and professional development, and patient support. Monetary value of in-kind contributions to start-up programs was also estimated.

Results: Start-up time ranged from 9 to 11 months for the five programs; costs ranged from $60,602 to $337,715. CDC funding and in-kind contributions were key resources for the program start-up activities. The budget category with the largest expenditure was labor, which on average accounted for 67% of start-up costs. The largest cost categories by activities were management (28%), database development (17%), administrative (17%), and quality assurance (12%). Other significant expenditures included public education and outreach (9%) and patient support (8%).

Conclusion: To our knowledge, no previous reports detail the costs to begin a colorectal cancer screening program for the underserved population. Start-up costs were significant, an important consideration in planning and budgeting. In-kind contributions were also critical in overall program funding. Start-up costs varied by the infrastructure available and the unique design of programs. These findings can inform development of organized colorectal cancer programs.

PubMed Disclaimer

Figures

Figure 1

Approach to collection of cost…

Figure 1

Approach to collection of cost data in study of start-up costs in five…

Figure 1

Approach to collection of cost data in study of start-up costs in five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.

Figure 2

Distribution of start-up costs, by…

Figure 2

Distribution of start-up costs, by budget category, in study of five programs in…

Figure 2

Distribution of start-up costs, by budget category, in study of five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.

Figure3

Percentage distribution of start-up costs, by…

Figure3

Percentage distribution of start-up costs, by activity, averaged across the five programs in the…

Figure3

Percentage distribution of start-up costs, by activity, averaged across the five programs in the Colorectal Cancer Screening Demonstration Program, 2005–2006. Numbers do not add up to 100% due to rounding.

Figure4

Distribution of start-up costs, by activity,…

Figure4

Distribution of start-up costs, by activity, in study of five programs in Colorectal Cancer…

Figure4

Distribution of start-up costs, by activity, in study of five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.

Similar articles Cited by References
    1. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000;95(4):868–877. - PubMed
    1. Subramanian S, Amonkar MM, Hunt TL. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2005;14(2):409–416. - PubMed
    1. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093–2103. - PubMed
    1. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):96–104. - PubMed
    1. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2007;50(1):34–49. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3